Mersana Therapeutics Inc. (MRSN)
NASDAQ: MRSN
· Real-Time Price · USD
7.15
-0.27 (-3.64%)
At close: Aug 15, 2025, 1:18 PM
Mersana Therapeutics Revenue
Mersana Therapeutics reported an annual revenue of $40.5M, reflecting a 9.88% growth. For the quarter ending June 30, 2025, Mersana Therapeutics generated $3.06M in revenue.
Revenue (ttm)
40.5M
Revenue Growth
9.88%
Price / Sales Ratio
4.33
Revenue / Employee
397.03K
Employees
102
Market Cap
35.64M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|